Streetbeat News

Analyst Ratings

PLD

RBC Capital analyst Michael Carroll has reiterated an Outperform rating on Prologis (NYSE:PLD) and maintained a $148 price target.

Portfolio Pulse from richadhand@benzinga.com

June 20, 2023 | 1:03 pm

RACE

Morgan Stanley analyst Adam Jonas reiterated an Overweight rating on Ferrari (NYSE:RACE) and maintained a $310 price target.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 1:03 pm

EPR

Analysts have provided ratings for EPR Props (NYSE:EPR) within the last quarter, with an average price target of $48.75, implying an upside from the current price of $45.8. The current average has increased by 8.33% from the previous average price target of $45.00.

Portfolio Pulse from Benzinga Insights

June 20, 2023 | 1:03 pm

HUM

RBC Capital analyst Ben Hendrix has reiterated an Outperform rating on Humana (NYSE:HUM) and maintained a $637 price target.

Portfolio Pulse from richadhand@benzinga.com

June 20, 2023 | 1:02 pm

PARA

In the last quarter, Paramount Global (NASDAQ:PARA) received 7 bullish, 1 indifferent, 1 somewhat bearish, and 1 bearish analyst ratings. The company has an average 12-month price target of $23.2, representing a 4.01% decrease from the previous average of $24.17.

Portfolio Pulse from Benzinga Insights

June 20, 2023 | 1:02 pm

TBLA

Analysts have provided bullish and somewhat bullish ratings for Taboola.com (NASDAQ:TBLA) in the last quarter, with an average price target of $5.0, implying an upside from the current price of $2.97. The average price target has increased by 11.11% from the previous average of $4.50.

Portfolio Pulse from Benzinga Insights

June 20, 2023 | 1:02 pm

EXAI

Morgan Stanley analyst Vikram Purohit reiterated an Equal-Weight rating on Exscientia (NASDAQ:EXAI) and maintained a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 1:02 pm

COLD

RBC Capital analyst Michael Carroll has reiterated an Outperform rating on Americold Realty Trust (NYSE:COLD) and maintained a $36 price target.

Portfolio Pulse from richadhand@benzinga.com

June 20, 2023 | 1:01 pm

CG

In the last 3 months, 13 analysts have offered 12-month price targets for Carlyle Group (NASDAQ:CG), with an average price target of $40.23, representing a 7.35% decrease from the previous average price target of $43.42.

Portfolio Pulse from Benzinga Insights

June 20, 2023 | 1:01 pm

MIST

Over the past 3 months, 5 analysts have published their opinion on Milestone Pharmaceuticals (NASDAQ:MIST) stock, with an average 12-month price target of $18.4, up 53.33% from the previous average of $12. The company has received 3 bullish, 1 somewhat bullish, and 1 indifferent rating.

Portfolio Pulse from Benzinga Insights

June 20, 2023 | 1:01 pm